PPARGC1A and multiple sclerosis: Activation of PGC-1α in astrocytes, a coactivator of mitochondrial biogenesis, therefore represents a promising therapeutic strategy to improve mitochondrial function and suppress inflammation in the model of multiple sclerosis (Nijland et al., 2014).